Emergent BioSolutions Receives Orphan Drug Designation for BioThrax...

Emergent BioSolutions Inc. announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to BioThraxA for post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed exposure to Bacillus anthracis .

http://ift.tt/1h4AUJI